Inventiva (IVA) Assets Average (2019 - 2025)
Inventiva (IVA) recorded quarterly Assets Average of $101.4 billion in Q4 2025, little changed quarter-over-quarter from $101.3 billion in Q2 2025, and up 137116.69% on a YoY basis from N/an in Q4 2024.
Inventiva (IVA) Assets Average (2019 - 2025) Analysis & Trends
Inventiva's Assets Average history runs 7 years deep, the most recent figure standing at $101.4 billion for Q4 2025.
- In Q4 2025, Assets Average rose 137116.69% year-over-year to $101.4 billion; the TTM figure through Dec 2025 stood at $101.4 billion (up 137116.69% YoY), while the FY2025 annual figure was $208.8 million, up 106.75% from the prior year.
- Assets Average was $101.4 billion for Q4 2025 at Inventiva, roughly flat from $101.3 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $101.4 billion in Q4 2025 to a low of $47.8 million in Q2 2024.
- Historically, Assets Average has averaged $22.6 billion across 5 years, with a median of $140.4 million in 2021.
- The sharpest annual moves came in 2022 and 2025: Assets Average sank 53.55% in 2022, then jumped 212025.45% in 2025.
- A 5-year view of Assets Average shows it stood at $140.4 million in 2021, then tumbled by 50.25% to $69.8 million in 2022, then declined by 21.38% to $54.9 million in 2023, then jumped by 34.64% to $73.9 million in 2024, then jumped by 137116.69% to $101.4 billion in 2025.
- The last three Assets Average figures came in at $101.4 billion (Q4 2025), $101.3 billion (Q2 2025), and $73.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 660.38 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 101.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.43 Bn |
| Jun 30, 2025 | 101.35 Bn |
| Dec 31, 2024 | 73.92 Mn |
| Jun 30, 2024 | 47.78 Mn |
| Dec 31, 2023 | 54.90 Mn |
| Jun 30, 2022 | 69.83 Mn |
| Dec 31, 2021 | 140.35 Mn |
| Jun 30, 2021 | 150.32 Mn |
| Mar 31, 2021 | 162.56 Mn |
| Dec 31, 2020 | 120.66 Mn |
| Dec 31, 2019 | 77.07 Mn |